Literature DB >> 9844065

Relationship of vacA genotypes of Helicobacter pylori to cagA status, cytotoxin production, and clinical outcome.

Y Yamaoka1, T Kodama, M Kita, J Imanishi, K Kashima, D Y Graham.   

Abstract

BACKGROUND: Mosaicism in vacA alleles with three distinct families of vacA signal sequences (s1a, s1b and s2) and two distinct families of middle region alleles (m1 and m2) has been reported. It was suggested that the vacA s1a genotype was closely associated with duodenal ulcer disease and with high cytotoxin production. The aim of this study was to evaluate the role of vacA genotyping with respect to gastric inflammation and injury, cytotoxin activity, and clinical presentation.
METHODS: H. pylori from patients with gastritis, peptic ulcer disease, or gastric cancer were characterized by vacA typing by polymerase chain reaction (PCR) and DNA sequencing. In vitro cytotoxin activity was assessed by vacuolation assay using Vero cells as well as with Hela cells.
RESULTS: Four hundred ninety-one strains were tested. vacA genotype s1a/m1 was present in more than 95% of strains independent of presentation with gastritis, peptic ulcer, or gastric cancer. No vacA genotype was associated with high average cytotoxin activity. The s2/m2 isolates had low or absent cytotoxin activity. All cagA negative strains (n = 18) were s1a strains and both s2/m2 strains were cagA positive. One strain that was a recombinant of m1 and m2 strains was identified and had low cytotoxin activity. The nucleotide and amino acid sequences between original m1 strains and Japanese m1 strains (new m1 strains) were about 85% and 81%, respectively. Strains with the new m1 genotype had nucleotide and amino acid sequences similarity of more than 96%. There was no difference in cytotoxin activity between strains with the Western type m1 and the new type m1 genotype.
CONCLUSION: In this as in other reported studies ( approximately 1500 patients overall) vacA genotype was strongly but not exclusively associated with the presence of cagA. Overall, the studies did not support a role for vacA genotyping in relation to cytotoxin activity, virulence, histologic finding, or risk of a particular H. pylori disease. vacA genotype s1 is likely to be a surrogate marker for the presence of the cag pathogenicity island.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9844065     DOI: 10.1046/j.1523-5378.1998.08056.x

Source DB:  PubMed          Journal:  Helicobacter        ISSN: 1083-4389            Impact factor:   5.753


  76 in total

1.  Helicobacter pylori vacA genotypes and cagA status and their relationship to associated diseases.

Authors:  Peng Hou; Zhen-Xing Tu; Guo-Ming Xu; Yan-Fang Gong; Xu-Hui Ji; Zhao-Shen Li
Journal:  World J Gastroenterol       Date:  2000-08       Impact factor: 5.742

2.  Discrimination between cases of duodenal ulcer and gastritis on the basis of putative virulence factors of Helicobacter pylori.

Authors:  Yoshio Yamaoka; Julianne Souchek; Stefan Odenbreit; Rainer Haas; Anna Arnqvist; Thomas Borén; Tadashi Kodama; Michael S Osato; Oscar Gutierrez; Jong G Kim; David Y Graham
Journal:  J Clin Microbiol       Date:  2002-06       Impact factor: 5.948

3.  The geographic origin of Helicobacter pylori influences the association of the homB gene with gastric cancer.

Authors:  Jieun Kang; Kathleen R Jones; Sungil Jang; Cara H Olsen; Yun-Jung Yoo; D Scott Merrell; Jeong-Heon Cha
Journal:  J Clin Microbiol       Date:  2012-01-11       Impact factor: 5.948

Review 4.  Clinical outcome of patients with Helicobacter pylori infection: the bug, the host, or the environment?

Authors:  S N Sgouros; C Bergele
Journal:  Postgrad Med J       Date:  2006-05       Impact factor: 2.401

5.  Helicobacter pylori outer membrane proteins and gastroduodenal disease.

Authors:  Y Yamaoka; O Ojo; S Fujimoto; S Odenbreit; R Haas; O Gutierrez; H M T El-Zimaity; R Reddy; A Arnqvist; D Y Graham
Journal:  Gut       Date:  2005-12-01       Impact factor: 23.059

6.  Clinical relevance of cagL gene and virulence genotypes with disease outcomes in a Helicobacter pylori infected population from Iran.

Authors:  Abbas Yadegar; Ashraf Mohabati Mobarez; Masoud Alebouyeh; Tabassom Mirzaei; Terry Kwok; Mohammad Reza Zali
Journal:  World J Microbiol Biotechnol       Date:  2014-05-23       Impact factor: 3.312

7.  Interleukin-17C in Human Helicobacter pylori Gastritis.

Authors:  Shingo Tanaka; Hiroyuki Nagashima; Modesto Cruz; Tomohisa Uchida; Takahiro Uotani; José A Jiménez Abreu; Varocha Mahachai; Ratha-Korn Vilaichone; Thawee Ratanachu-Ek; Lotay Tshering; David Y Graham; Yoshio Yamaoka
Journal:  Infect Immun       Date:  2017-09-20       Impact factor: 3.441

Review 8.  Polymorphism in the Helicobacter pylori CagA and VacA toxins and disease.

Authors:  Dacie R Bridge; D Scott Merrell
Journal:  Gut Microbes       Date:  2013-02-04

9.  Comparison of genotyping Helicobacter pylori directly from biopsy specimens and genotyping from bacterial cultures.

Authors:  Chang-Young Park; Minjung Kwak; Oscar Gutierrez; David Y Graham; Yoshio Yamaoka
Journal:  J Clin Microbiol       Date:  2003-07       Impact factor: 5.948

10.  Intact long-type dupA as a marker for gastroduodenal diseases in Okinawan subpopulation, Japan.

Authors:  Ayaka Takahashi; Seiji Shiota; Osamu Matsunari; Masahide Watada; Rumiko Suzuki; Saori Nakachi; Nagisa Kinjo; Fukunori Kinjo; Yoshio Yamaoka
Journal:  Helicobacter       Date:  2012-08-22       Impact factor: 5.753

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.